Versant Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$76.7K Sell
4,579
-718
-14% -$12K 0.01% 786
2025
Q1
$81.4K Buy
5,297
+4,312
+438% +$66.3K 0.01% 697
2024
Q4
$21.7K Buy
985
+760
+338% +$16.8K ﹤0.01% 987
2024
Q3
$4.06K Buy
+225
New +$4.06K ﹤0.01% 1360